Cullinan Therapeutics, Inc. (CGEM)
8.91
-0.16
(-1.76%)
USD |
NASDAQ |
Nov 20, 16:00
8.91
0.00 (0.00%)
After-Hours: 20:00
Cullinan Therapeutics Gross Profit (TTM) : -0.29M for Sept. 30, 2026
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| September 30, 2026 | -0.29M |
| June 30, 2026 | -0.316M |
| March 31, 2026 | -0.314M |
| December 31, 2025 | -0.311M |
| September 30, 2025 | -0.309M |
| June 30, 2025 | -0.306M |
| March 31, 2025 | -0.306M |
| December 31, 2024 | -0.306M |
| September 30, 2024 | -0.306M |
| June 30, 2024 | -0.31M |
| March 31, 2024 | -0.314M |
| December 31, 2023 | -0.31M |
| September 30, 2023 | -0.292M |
| June 30, 2023 | -0.221M |
| March 31, 2023 | -0.14M |
| Date | Value |
|---|---|
| December 31, 2022 | -0.068M |
| September 30, 2022 | -0.021M |
| June 30, 2022 | -0.025M |
| March 31, 2022 | -0.038M |
| December 31, 2021 | -0.038M |
| September 30, 2021 | -0.041M |
| June 30, 2021 | -0.043M |
| March 31, 2021 | -0.046M |
| December 31, 2020 | -0.062M |
| September 30, 2020 | -0.064M |
| June 30, 2020 | -0.065M |
| March 31, 2020 | -0.049M |
| December 31, 2019 | -0.033M |
| September 30, 2019 | -0.016M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Climb Bio, Inc. | -0.296M |
| Oncolytics Biotech, Inc. | -0.048M |
| Sangamo Therapeutics, Inc. | 28.00M |
| Sarepta Therapeutics, Inc. | 1.074B |
| Anixa Biosciences, Inc. | -0.039M |